The current state of biomarker research for Friedreich’s ataxia: a report from the 2018 FARA biomarker meeting

The 2018 FARA Biomarker Meeting highlighted the current state of development of biomarkers for Friedreich’s ataxia. A mass spectroscopy assay to sensitively measure mature frataxin (reduction of which is the root cause of disease) is being developed. Biomarkers to monitor neurological disease progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Blair, Ian A, Farmer, Jennifer, Hersch, Steven, Larkindale, Jane, Lynch, David R, Napierala, Jill, Napierala, Marek, Payne, R Mark, Subramony, Sub H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609901/
https://www.ncbi.nlm.nih.gov/pubmed/31285843
http://dx.doi.org/10.2144/fsoa-2019-0026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609901/
https://www.ncbi.nlm.nih.gov/pubmed/31285843
http://dx.doi.org/10.2144/fsoa-2019-0026

Ejemplares similares